AnaptysBio has reported that the ARISE-AD trial of its investigational B and T lymphocyte attenuator (BTLA) agonist, ANB032, ...

Dupilumab treatment improves signs and symptoms of atopic dermatitis (AD) in young children, according to a study published ...

As previously reported, Guggenheim downgraded Q32 Bio (QTTB) to Neutral from Buy and removed the firm’s prior price target following the ...

In allergen-driven models of atopic dermatitis, subcutaneous (SQ) administration of ‘1104 demonstrated comparable performance to intravenous administration (IV) In multiple preclinical models ...

Guggenheim lowered the firm’s price target on AnaptysBio (ANAB) to $36 from $90 and keeps a Buy rating on the shares following the announcement ...

Shares of QTTB fall after its experimental autoimmune disease drug failed to meet the primary endpoint in a mid-stage study for eczema.

Shield your child from winter's harsh skin conditions! Learn to identify and prevent common issues like dry skin, eczema, and ...

Watch out for these 10 early warning signs of cancer that vulnerable individuals must be aware of, so as to seek early medical intervention.

Shares of AnaptysBio Inc. remained flat in premarket trading Thursday after plunging over 32% in the prior session, marking ...

If a child’s skin condition persists or worsens despite home care, consult a dermatologist or pediatrician. Signs to watch ...

Skipping moisturiser is a big no, even for people with oily skin. This skincare product not only hydrates the skin but also ...

In the continuation of our discussion with Chris Sayed, MD, University of North Carolina at Chapel Hill Department of ...